NCI Evaluation of COVID-19 Tests

The FDA worked with a number of agencies in efforts to evaluate the sensitivity and specificity of various COVID-19 serology tests.


Test sensitivity is the ability of a test to correctly identify those with the disease (true positive rate), whereas test specificity is the ability of the test to correctly identify those without the disease (true negative rate).


See the report here:

https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3247-a001.pdf




Company

About Healgen

News

Support

Contact Us

Privacy Policy

2020 © Healgen Scientific, LLC. All Rights Reserved. 

Follow Us

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter